When a routine investigation by New Zealand authorities revealed alarming gaps in the protocols for managing health data, the country found itself grappling with an urgent and complex challenge. In an era where data breaches are becoming increasingly frequent and sophisticated, the protection of
Fosun Pharmaceutical, a leading Chinese pharmaceutical conglomerate, recently attempted to take full control of its biopharma subsidiary, Henlius Biotech, by purchasing the remaining minority shares. This strategic move aimed to consolidate Henlius under Fosun's complete ownership, leveraging
The Contract Development and Manufacturing Organization (CDMO) sector is navigating a landscape marked by significant changes and evolving trends. Gil Roth, President of the Pharma & Biopharma Outsourcing Association, provides a comprehensive analysis of the sector's current state and
The healthcare investment landscape has undergone significant transformations in recent years, driven by various factors including the COVID-19 pandemic, technological advancements, and strategic shifts within the industry. As we delve into 2024, it is crucial to understand the key trends and
In recent years, the healthcare industry has experienced a paradigm shift due to the rapid advancement of telemedicine technologies and the strategic investments made by pharmaceutical, medical device, and digital therapeutics (DTx) companies. The surge in telehealth investments is primarily driven
As the biopharma and life sciences sector maneuvers through a turbulent economic landscape, organizations face the daunting challenge of balancing costs with the need to attract and retain top talent. This industry-specific balancing act becomes all the more critical as we look ahead to the year
